Compare ASIC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASIC | IART |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | United States | United States |
| Employees | 203 | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2025 | 1996 |
| Metric | ASIC | IART |
|---|---|---|
| Price | $26.39 | $16.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | ★ $29.10 | $19.56 |
| AVG Volume (30 Days) | 51.7K | ★ 725.5K |
| Earning Date | 10-21-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.44 | N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $424,339,000.00 | N/A |
| Revenue This Year | $27.91 | $2.40 |
| Revenue Next Year | $25.28 | $3.17 |
| P/E Ratio | $22.21 | ★ N/A |
| Revenue Growth | ★ 23.41 | N/A |
| 52 Week Low | $16.35 | $8.70 |
| 52 Week High | $29.00 | $20.49 |
| Indicator | ASIC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 50.17 |
| Support Level | $18.75 | $16.04 |
| Resistance Level | $27.22 | $16.38 |
| Average True Range (ATR) | 0.80 | 0.62 |
| MACD | -0.30 | 0.14 |
| Stochastic Oscillator | 11.16 | 74.87 |
Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.